Unseen Costs of MS

News

Richard Saynor's BBC interview

Sandoz reports strong FY 2024 results and Q4 2024 sales

<a href="/sandoz-reports-strong-fy-2024-results-and-q4-2024-sales">Read the media release</a>

<a href="https://sandoz-com.cms.sandoz.com/sites/default/files/Media%20Documents/Sandoz_2024_annual_report.pdf">Download the 2024 Integrated Annual Report</a>

<a href="https://sandoz-com.cms.sandoz.com/sites/default/files/Media%20Documents/Sandoz_2024_FY_IR_slides.pdf">Download the analyst and investor presentation</a>

<a href="https://sandoz-full-year-results-2024.open-exchange.net/">Watch the webcast</a> (9am CET)

<a href="/investors/financials">Read more about our financials</a>

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally.